Daxx promotes DNA damage repair through homologous recombination and inhibits cGAS-STING signal activation, suggesting that Daxx impairs colon cancer chemotherapy by restricting the cGAS-STING signal activation to mediate antitumor immune responses. Here, DAXX is linked to malignant colon neoplasm.